The acquisition will help Zimmer Biomet to expand its hip reconstruction product portfolio. Credit: Tom Claes on Unsplash.

Zimmer Biomet has entered a definitive agreement for the acquisition of privately-held medical device company OSSIS for an undisclosed sum.

OSSIS provides personalised 3D printed implants and complex hip replacements such as second-time hip replacements and those involving bone tumours and trauma.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company offers rapid design and manufacturing of personalised implants. Zimmer Biomet is focused on delivering personalised experiences to enhance patient outcomes.

OSSIS managing director Kelvin Hyland said: “Zimmer Biomet shares our ethos of innovative technology with a strong patient focus and OSSIS is thrilled to join Zimmer Biomet’s established portfolio with cutting-edge solutions and expert capabilities.”

In July 2021, Zimmer was selected as OSSIS’ partner to exclusively distribute the latter’s patient-specific 3D-printed titanium hip joint replacements and other pelvic bone replacement surgery products in the Asia Pacific region.

In December 2022, the companies expanded the partnership to cover Europe, the Middle East and Africa.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The acquisition is expected to enable Zimmer Biomet to expand its hip reconstruction product portfolio.

Zimmer Biomet Asia Pacific Group president Sang Yi said: “Combining OSSIS’s more than 16 years of clinical experience and engineering expertise with Zimmer Biomet’s extensive network across Asia Pacific, Europe, Middle East and Africa demonstrates our commitment to bring transformative med tech advancements to patients in need.

“We are very pleased to partner with these patients and their physicians as we work toward our mission to alleviate pain and improve the quality of life for people around the world.”

In January this year, Zimmer Biomet agreed to acquire US-based medical device company Embody for $155m.